The therapeutic potential of cannabisDavid Baker, Alan J. Thompson, Gareth Pryce et al.|The Lancet Neurology|2003Cited by 346
Cannabinoids inhibit neurodegeneration in models of multiple sclerosisGareth Pryce, David Baker, Zubair Ahmed et al.|Brain|2003Cited by 341
Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumabPer Soelberg Sørensen, Tomas Olsson, Antonio Bertolotto et al.|Multiple Sclerosis Journal|2012Cited by 236
The Multiple Sclerosis Care UnitPer Soelberg Sørensen, Gıancarlo Comı, Gavin Giovannoni et al.|Multiple Sclerosis Journal|2018Cited by 157
Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile EffectsJerold Chun, Samuel F. Hunter, Gavin Giovannoni|Drugs|2020Cited by 155